【Prognostic Factors in Geriatric Patients with Metastatic Colon Cancer】

Colorectal_cancer is an important threat to human health and the third most common type of cancer worldwide. In the past decade, significant advances have been made in the treatment of metastatic colorectal cancer. The development of cytotoxic therapies and targeted agents has improved the median survival time. However, given that many older adult patients often have concomitant diseases and impairments in organ function, they are at increased risk for chemotherapy toxicity. In this paper, the researchers examined the #prognostic_factors that are associated with overall survival (OS) in older patients (aged 65 and older) with colorectal cancer undergoing #chemotherapy. #Comprehensive_Geriatric_Assessment